Nanocopoeia
Pharmaceuticals, 639 Campus Dr, New Brighton, Minnesota, 55112, United States, 11-50 Employees
Phone Number: 65********
Who is NANOCOPOEIA
We are a privately held company in the Twin Cities (MN) area founded in 2001 through a technology license with University of Minnesota. Our initial technology focused towards medical devi...
Read More
-
Headquarters: 639 Campus Dr, New Brighton, Minnesota, 55112, United States
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 621111 |
Show More
Does something look wrong? Fix it. | View contact records from NANOCOPOEIA
Nanocopoeia Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Nanocopoeia
Answer: Nanocopoeia's headquarters are located at 639 Campus Dr, New Brighton, Minnesota, 55112, United States
Answer: Nanocopoeia's phone number is 65********
Answer: Nanocopoeia's official website is https://nanocopoeia.com
Answer: Nanocopoeia's revenue is $10 Million to $25 Million
Answer: Nanocopoeia's SIC: 2834
Answer: Nanocopoeia's NAICS: 621111
Answer: Nanocopoeia has 11-50 employees
Answer: Nanocopoeia is in Pharmaceuticals
Answer: Nanocopoeia contact info: Phone number: 65******** Website: https://nanocopoeia.com
Answer: We are a privately held company in the Twin Cities (MN) area founded in 2001 through a technology license with University of Minnesota. Our initial technology focused towards medical devices and advanced nano-scale coating processes within a busines-to-business technology services model. We recently reorganized and restructured to scale-up technology, generate macro-particles for oral-solid drug development. We have demonstrated a strong proof-of-concept in enhancing low solubility drug performance and solid progress across our target drug pipeline. Our product enhancements span patient safety, convenience, compliance and effectiveness that have been achieved by overcoming challenging insolubility issues, increasing bio-availability performance and dramatically reducing defects. Substantial investment from investors has made building a technically accomplished team and experienced industry management to create valuable 505(b)(2) opportunities a reality.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month